Fundz

Alzheon, Inc. reported raising $15.8 Million in an initial SEC Form D filing, from an offering of $15.8 Million

PRIVATEJun 09, 2017

Amount Raised

$15.8 Million

$15.8 Million sold, per SEC Form D (first sale Jun 9, 2017)

Round Type

Venture

FraminghamBiotechnology

Quick answer

Alzheon raised $15.8 Million in a funding round, dated June 9, 2017. Alzheon is based in Framingham, Massachusetts, United States.

How much did Alzheon raise?
Alzheon raised $15.8 Million in a funding round on June 9, 2017.
What does Alzheon do?
Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.
Where is Alzheon based and how big is it?
Alzheon is based in Framingham, Massachusetts, United States. Fundz records about 31 employees.
Who are the decision-makers at Alzheon?
Fundz holds 1 contact at Alzheon, including the Director, Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Alzheon that raised within 45 days of this round, from Fundz verified event records.

  • Tarsa Therapeutics, Inc. raised $550K (Seed) on July 24, 2017.
  • Alpine Immune Sciences, Inc. raised $17M on July 24, 2017.
  • Cardiff Oncology raised an undisclosed amount on July 24, 2017.
  • Trevi Therapeutics raised $41M on July 24, 2017.
  • Aspyrian Therapeutics, Inc. raised $15M on July 21, 2017.
  • Novopyxis Inc. raised $513K (Seed) on July 21, 2017.

Who to call at Alzheon, and when

A new round usually means Alzheon is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alzheon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alzheon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alzheon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alzheon

Location

111 Speen Street

Framingham, Massachusetts, United States

About

Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimer’s clinical candidate, ALZ-801, is an oral small molecule prodrug of tramiprosate that fully blocks formation of neurotoxic soluble amyloid oligomers in the brain. ALZ-801 is an easy-to-take tablet that builds on the safety and efficacy profile of its active compound tramiprosate, which has been evaluated in clinical trials involving over 2,000 Alzheimer’s patients. Our clinical expertise and technology platform are focused on developing drug candidates using a precision medicine approach based on individual genetic and biological information to advance therapies with the greatest impact for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alzheon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMartin T., Director, Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Alzheon's next move

See what Strategic adds

Alzheon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.